The company is facing lawsuits over allegations that its baby powder and other products caused cancer AlamyAllegations that its baby powder products contained asbestos were brushed off by Johnson & Johnson yesterday as it reported strong first-quarter drugs sales and raised its full-year revenue forecast. Pharmaceuticals sales, the largest contributor to Johnson & Johnson’s revenue, rose by 4.1 per cent compared with the same quarter of 2018 to $10.2 billion. Johnson & Johnson is the world’s largest healthcare company, valued at $373 billion. It faces thousands of lawsuits over allegations that its talc-based baby powder and other personal care products have caused cancer in women. Consumer sales fell by 2.4 per cent in the first quarter to $3.3 billion, mainly because of a decline in sales of babycare products.

Source: The Times April 16, 2019 23:09 UTC